Primary parotid lymphoma from a regional cancer center in South India
Background and Purpose: Primary parotid lymphoma (PPL) is an unusual entity and comprises 5% of salivary gland neoplasms and 5% of extra nodal lymphomas. There is limited data in Indian population. Hence we undertook this retrospective observational study of primary parotid lymphoma at our centre...
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
PAGEPress Publications
2014-08-01
|
| Series: | Mediterranean Journal of Hematology and Infectious Diseases |
| Subjects: | |
| Online Access: | https://mjhid.org/index.php/mjhid/article/view/1795 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850215949387431936 |
|---|---|
| author | Lakshmaiah KC Vishwanath Sathyanarayanan Lokesh KN Premalatha CS Clementina Rama Rao Suresh TM Govind Babu K Lokanatha D Linu Abraham Jacob Umesh Das Suresh Babu |
| author_facet | Lakshmaiah KC Vishwanath Sathyanarayanan Lokesh KN Premalatha CS Clementina Rama Rao Suresh TM Govind Babu K Lokanatha D Linu Abraham Jacob Umesh Das Suresh Babu |
| author_sort | Lakshmaiah KC |
| collection | DOAJ |
| description | Background and Purpose: Primary parotid lymphoma (PPL) is an unusual entity and
comprises 5% of salivary gland neoplasms and 5% of extra nodal lymphomas. There is
limited data in Indian population. Hence we undertook this retrospective observational study
of primary parotid lymphoma at our centre in Southern India.
Results: 7 consecutive cases diagnosed as PPL by tissue biopsy/superficial/deep
parotidectomy confirmed by immunohistochemistry between 2007 and 2012 were included.
Median age was 54 years(29-78), and it was more common in males. Diffuse large B cell
lymphoma was seen in 6 and extra nodal marginal zone lymphoma in 1. According to Ann
Arbor stage- Advanced stage (stage III and IV) was seen in 2(28.57%). According to the
International Prognostic Index most were in low risk- 6 (85.7%). Overall survival range from
1-45 months, with a median survival of 24 months.
Conclusions: To conclude, PPL presents more often in early stage and low IPI score. Surgery
with chemoimmunotherapy with involved field radiotherapy remains the standard treatment
at present. |
| format | Article |
| id | doaj-art-7df99552127d49ceaebd38ebc81f690d |
| institution | OA Journals |
| issn | 2035-3006 |
| language | English |
| publishDate | 2014-08-01 |
| publisher | PAGEPress Publications |
| record_format | Article |
| series | Mediterranean Journal of Hematology and Infectious Diseases |
| spelling | doaj-art-7df99552127d49ceaebd38ebc81f690d2025-08-20T02:08:27ZengPAGEPress PublicationsMediterranean Journal of Hematology and Infectious Diseases2035-30062014-08-011Primary parotid lymphoma from a regional cancer center in South IndiaLakshmaiah KCVishwanath Sathyanarayanan0Lokesh KNPremalatha CSClementina Rama RaoSuresh TMGovind Babu KLokanatha DLinu Abraham JacobUmesh DasSuresh BabuDepartment of Medical Oncology, Kidwai Memorial Institute of Oncology, Bangalore, Karnataka, IndiaBackground and Purpose: Primary parotid lymphoma (PPL) is an unusual entity and comprises 5% of salivary gland neoplasms and 5% of extra nodal lymphomas. There is limited data in Indian population. Hence we undertook this retrospective observational study of primary parotid lymphoma at our centre in Southern India. Results: 7 consecutive cases diagnosed as PPL by tissue biopsy/superficial/deep parotidectomy confirmed by immunohistochemistry between 2007 and 2012 were included. Median age was 54 years(29-78), and it was more common in males. Diffuse large B cell lymphoma was seen in 6 and extra nodal marginal zone lymphoma in 1. According to Ann Arbor stage- Advanced stage (stage III and IV) was seen in 2(28.57%). According to the International Prognostic Index most were in low risk- 6 (85.7%). Overall survival range from 1-45 months, with a median survival of 24 months. Conclusions: To conclude, PPL presents more often in early stage and low IPI score. Surgery with chemoimmunotherapy with involved field radiotherapy remains the standard treatment at present.https://mjhid.org/index.php/mjhid/article/view/1795Extra nodalparotidlymphomaIndia |
| spellingShingle | Lakshmaiah KC Vishwanath Sathyanarayanan Lokesh KN Premalatha CS Clementina Rama Rao Suresh TM Govind Babu K Lokanatha D Linu Abraham Jacob Umesh Das Suresh Babu Primary parotid lymphoma from a regional cancer center in South India Mediterranean Journal of Hematology and Infectious Diseases Extra nodal parotid lymphoma India |
| title | Primary parotid lymphoma from a regional cancer center in South India |
| title_full | Primary parotid lymphoma from a regional cancer center in South India |
| title_fullStr | Primary parotid lymphoma from a regional cancer center in South India |
| title_full_unstemmed | Primary parotid lymphoma from a regional cancer center in South India |
| title_short | Primary parotid lymphoma from a regional cancer center in South India |
| title_sort | primary parotid lymphoma from a regional cancer center in south india |
| topic | Extra nodal parotid lymphoma India |
| url | https://mjhid.org/index.php/mjhid/article/view/1795 |
| work_keys_str_mv | AT lakshmaiahkc primaryparotidlymphomafromaregionalcancercenterinsouthindia AT vishwanathsathyanarayanan primaryparotidlymphomafromaregionalcancercenterinsouthindia AT lokeshkn primaryparotidlymphomafromaregionalcancercenterinsouthindia AT premalathacs primaryparotidlymphomafromaregionalcancercenterinsouthindia AT clementinaramarao primaryparotidlymphomafromaregionalcancercenterinsouthindia AT sureshtm primaryparotidlymphomafromaregionalcancercenterinsouthindia AT govindbabuk primaryparotidlymphomafromaregionalcancercenterinsouthindia AT lokanathad primaryparotidlymphomafromaregionalcancercenterinsouthindia AT linuabrahamjacob primaryparotidlymphomafromaregionalcancercenterinsouthindia AT umeshdas primaryparotidlymphomafromaregionalcancercenterinsouthindia AT sureshbabu primaryparotidlymphomafromaregionalcancercenterinsouthindia |